KRAS and colorectal cancer: Overall, for patients with colorectal cancer, the impact of KRAS mutations on survival is not fully clear—certainly, those with KRAS mutations on codon 12 have worse outcomes, but those with codon 13 mutations may have similar outcomes to patients with wild-type KRAS [34].